FDMT earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -4.12. Updated 2026-07-23.
4D Molecular Therapeutics (FDMT) Research Hub
4D Molecular Therapeutics (FDMT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 13.17 USD (-7.12%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.12, market cap 0.58B. This hub links to the full technical, earnings and options research available for FDMT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 13.17 USD (-7.12%) |
| 52-week range | 8.73 USD – 16.93 USD |
| Trend regime | Range |
| 14-day RSI | 61.2 (Bullish) |
| Trailing P/E | -4.12 |
| Market cap | 0.58B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for FDMT
Covered Call on FDMT: how it works, illustrative setup around the real 13.17 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FDMT: how it works, illustrative setup around the real 13.17 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FDMT: how it works, illustrative setup around the real 13.17 USD price, max profit/loss, breakeven and when to use it. Educational.
FDMT technical analysis: range, last 13.17 USD, RSI 61.2, 52w range 8.73 USD–16.93 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is FDMT in?
4D Molecular Therapeutics (FDMT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FDMT in an uptrend or downtrend?
As of 2026-09-11, FDMT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FDMT's trailing P/E ratio?
FDMT's trailing P/E is -4.12, with a market cap of 0.58B. See the earnings research page for full valuation detail.
When does FDMT next report earnings?
FDMT is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -1.04 USD.